498 related articles for article (PubMed ID: 19527108)
1. Gene therapy for muscular dystrophy: current progress and future prospects.
Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy progress and prospects: Duchenne muscular dystrophy.
Foster K; Foster H; Dickson JG
Gene Ther; 2006 Dec; 13(24):1677-85. PubMed ID: 17066097
[TBL] [Abstract][Full Text] [Related]
3. [Molecular therapy of muscular dystrophy].
Takeda S
Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
[TBL] [Abstract][Full Text] [Related]
4. Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
Aartsma-Rus A; Janson AA; van Ommen GJ; van Deutekom JC
BMC Med Genet; 2007 Jul; 8():43. PubMed ID: 17612397
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic strategy for muscular dystrophies].
Shin JH; Takeda S
Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
[TBL] [Abstract][Full Text] [Related]
6. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
Jørgensen LH; Larochelle N; Orlopp K; Dunant P; Dudley RW; Stucka R; Thirion C; Walter MC; Laval SH; Lochmüller H
Hum Gene Ther; 2009 Jun; 20(6):641-50. PubMed ID: 19239382
[TBL] [Abstract][Full Text] [Related]
7. Induced dystrophin exon skipping in human muscle explants.
McClorey G; Fall AM; Moulton HM; Iversen PL; Rasko JE; Ryan M; Fletcher S; Wilton SD
Neuromuscul Disord; 2006 Oct; 16(9-10):583-90. PubMed ID: 16919955
[TBL] [Abstract][Full Text] [Related]
8. Splicing intervention for Duchenne muscular dystrophy.
McClorey G; Fletcher S; Wilton S
Curr Opin Pharmacol; 2005 Oct; 5(5):529-34. PubMed ID: 16085461
[TBL] [Abstract][Full Text] [Related]
9. AAV-directed muscular dystrophy gene therapy.
Tang Y; Cummins J; Huard J; Wang B
Expert Opin Biol Ther; 2010 Mar; 10(3):395-408. PubMed ID: 20132060
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for Duchenne and Becker dystrophies.
Voisin V; de la Porte S
Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
[TBL] [Abstract][Full Text] [Related]
11. [Current state and prospects for gene therapy of Duchenne muscular dystrophy in the world and in Russia].
Baranov VS; Baranov AN; Zelenin AV
Genetika; 2001 Aug; 37(8):1046-54. PubMed ID: 11642103
[TBL] [Abstract][Full Text] [Related]
12. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
Stedman HH
Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
[TBL] [Abstract][Full Text] [Related]
13. Development of therapy for Duchenne muscular dystrophy.
Zhang S; Xie H; Zhou G; Yang Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
[TBL] [Abstract][Full Text] [Related]
14. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
[TBL] [Abstract][Full Text] [Related]
15. Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
Heemskerk H; de Winter CL; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
Ann N Y Acad Sci; 2009 Sep; 1175():71-9. PubMed ID: 19796079
[TBL] [Abstract][Full Text] [Related]
16. The principles of gene therapy in Duchenne muscular dystrophy.
Karpati G; Acsadi G
Clin Invest Med; 1994 Oct; 17(5):499-509. PubMed ID: 7867254
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to muscular dystrophy.
Goyenvalle A; Seto JT; Davies KE; Chamberlain J
Hum Mol Genet; 2011 Apr; 20(R1):R69-78. PubMed ID: 21436158
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
Blankinship MJ; Gregorevic P; Chamberlain JS
Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
[TBL] [Abstract][Full Text] [Related]
20. Current status of gene therapy for muscle diseases.
Thirion C; Lochmüller H
Drug News Perspect; 2007; 20(6):357-63. PubMed ID: 17925889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
